These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35634961)

  • 21. Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
    Goswami C; Sheldon M; Bixby C; Keddache M; Bogdanowicz A; Wang Y; Schultz J; McDevitt J; LaPorta J; Kwon E; Buyske S; Garbolino D; Biloholowski G; Pastuszak A; Storella M; Bhalla A; Charlier-Rodriguez F; Hager R; Grimwood R; Nahas SA
    BMC Infect Dis; 2022 Apr; 22(1):404. PubMed ID: 35468749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficient SARS-CoV-2 Surveillance during the Pandemic-Endemic Transition Using PCR-Based Genotyping Assays.
    Koets L; van Leeuwen K; Derlagen M; van Wijk J; Keijzer N; Feenstra JDM; Gandhi M; Sorel O; van de Laar TJW; Koppelman MHGM
    Microbiol Spectr; 2023 Jun; 11(3):e0345022. PubMed ID: 37154727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term monitoring of SARS-CoV-2 variants in wastewater using a coordinated workflow of droplet digital PCR and nanopore sequencing.
    Vigil K; D'Souza N; Bazner J; Cedraz FM; Fisch S; Rose JB; Aw TG
    Water Res; 2024 May; 254():121338. PubMed ID: 38430753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021.
    Subramoney K; Mtileni N; Bharuthram A; Davis A; Kalenga B; Rikhotso M; Maphahlele M; Giandhari J; Naidoo Y; Pillay S; Ramphal U; Ramphal Y; Tegally H; Wilkinson E; Mohale T; Ismail A; Mashishi B; Mbenenge N; de Oliveira T; Makatini Z; Fielding BC; Treurnicht FK;
    J Med Virol; 2022 Aug; 94(8):3676-3684. PubMed ID: 35441368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern.
    Pinkhover NP; Pontbriand KM; Fletcher KP; Sanchez E; Okello K; Garvey LM; Pum A; Li K; DeOliveira G; Proctor T; Feenstra JDM; Sorel O; Gandhi M; Auclair JR
    Microbiol Spectr; 2024 Feb; 12(2):e0348423. PubMed ID: 38206048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A straightforward one-step strategy for SARS-CoV-2 diagnosis and screening of variants of concern: a multicentre study.
    Fontana-Maurell M; Motta FDC; Arruda MB; Cardoso P; Ribeiro M; Andrade E; Godoy DT; Costa E; Rocha D; Siqueira MAM; Brindeiro R; Alvarez P
    Mem Inst Oswaldo Cruz; 2023; 118():e220202. PubMed ID: 36946838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wastewater Genomic Surveillance Captures Early Detection of Omicron in Utah.
    Gupta P; Liao S; Ezekiel M; Novak N; Rossi A; LaCross N; Oakeson K; Rohrwasser A
    Microbiol Spectr; 2023 Jun; 11(3):e0039123. PubMed ID: 37154725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
    Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
    Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2.
    Vogels CBF; Breban MI; Ott IM; Alpert T; Petrone ME; Watkins AE; Kalinich CC; Earnest R; Rothman JE; Goes de Jesus J; Morales Claro I; Magalhães Ferreira G; Crispim MAE; ; Singh L; Tegally H; Anyaneji UJ; ; Hodcroft EB; Mason CE; Khullar G; Metti J; Dudley JT; MacKay MJ; Nash M; Wang J; Liu C; Hui P; Murphy S; Neal C; Laszlo E; Landry ML; Muyombwe A; Downing R; Razeq J; de Oliveira T; Faria NR; Sabino EC; Neher RA; Fauver JR; Grubaugh ND
    PLoS Biol; 2021 May; 19(5):e3001236. PubMed ID: 33961632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study.
    Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN
    Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia's surveillance system performance.
    Lokuge K; D'Onise K; Banks E; Street T; Jantos S; Baptista M; Glass K
    BMC Med; 2022 Apr; 20(1):157. PubMed ID: 35421989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program.
    Jung A; Droit L; Febles B; Fronick C; Cook L; Handley SA; Parikh BA; Wang D
    Microbiol Spectr; 2024 Aug; 12(8):e0422523. PubMed ID: 38912809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.
    Nyberg T; Twohig KA; Harris RJ; Seaman SR; Flannagan J; Allen H; Charlett A; De Angelis D; Dabrera G; Presanis AM
    BMJ; 2021 Jun; 373():n1412. PubMed ID: 34130987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancing Precision Vaccinology by Molecular and Genomic Surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 in Germany, 2021.
    Oh DY; Hölzer M; Paraskevopoulou S; Trofimova M; Hartkopf F; Budt M; Wedde M; Richard H; Haldemann B; Domaszewska T; Reiche J; Keeren K; Radonić A; Ramos Calderón JP; Smith MR; Brinkmann A; Trappe K; Drechsel O; Klaper K; Hein S; Hildt E; Haas W; Calvignac-Spencer S; Semmler T; Dürrwald R; Thürmer A; Drosten C; Fuchs S; Kröger S; von Kleist M; Wolff T;
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S110-S120. PubMed ID: 35749674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.
    Lambrou AS; Shirk P; Steele MK; Paul P; Paden CR; Cadwell B; Reese HE; Aoki Y; Hassell N; Zheng XY; Talarico S; Chen JC; Oberste MS; Batra D; McMullan LK; Halpin AL; Galloway SE; MacCannell DR; Kondor R; Barnes J; MacNeil A; Silk BJ; Dugan VG; Scobie HM; Wentworth DE; Caravas J; Kovacs NA; Gerhart JG; Jia Ng H; Beck A; Chau R; Cintron R; Cook PW; Gulvik CA; Howard D; Jang Y; Knipe K; Lacek KA; Moser KA; Paskey AC; Rambo-Martin BL; Nagilla RR; Retchless AC; Schmerer MW; Seby S; Shepard SS; Stanton RA; Stark TJ; Uehara A; Unoarumhi Y; Bentz ML; Burgin A; Burroughs M; Davis ML; Keller MW; Keong LM; Le SS; Lee JS; Madden Jr JC; Nobles S; Owuor DC; Padilla J; Sheth M; Wilson MM; ;
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):206-211. PubMed ID: 35143464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations.
    Spiess K; Gunalan V; Marving E; Nielsen SH; Jørgensen MGP; Fomsgaard AS; Nielsen L; Alfaro-Núñez A; Karst SM; ; Mortensen S; Rasmussen M; Lassaunière R; Rosenstierne MW; Polacek C; Fonager J; Cohen AS; Nielsen C; Fomsgaard A
    Microbiol Spectr; 2023 Feb; 11(1):e0359122. PubMed ID: 36625603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico.
    Santiago GA; Volkman HR; Flores B; González GL; Charriez KN; Huertas LC; Van Belleghem SM; Rivera-Amill V; Major C; Colon C; Tosado R; Adams LE; Marzán M; Hernández L; Cardona I; O'Neill E; Paz-Bailey G; Papa R; Muñoz-Jordan JL
    Emerg Infect Dis; 2023 Apr; 29(4):855-857. PubMed ID: 36878014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay.
    Ippoliti C; De Maio F; Santarelli G; Marchetti S; Vella A; Santangelo R; Sanguinetti M; Posteraro B
    Microbiol Spectr; 2022 Aug; 10(4):e0099022. PubMed ID: 35863025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.